Toyota's new fuel cell delivers 20% more cruising range and offers two times more durability than the prior generation.
AlphaPEM is an open-source software package for simulating proton exchange membrane fuel cell (PEMFC) systems using physics-based models for embedded applications.
Jan 28 (Reuters) - Apple's (AAPL.O), opens new tab iPhone devices are now eligible to test SpaceX-owned Starlink's direct-to-cell capability that provides coverage from space, according to T ...
Neurons are cells in the body that are responsible for transmitting electrical signals through the nervous system. Different types of neurons affect the ability to move, which begins as an impulse, or ...
"This was not an easy decision to make given the impact on the approximately 1,100 people who work there and local producers. However, it is the right move to make for the future of our turkey ...
Quordle was one of the original Wordle alternatives and is still going strong now more than 1,000 games later. It offers a genuine challenge, though, so read on if you need some Quordle hints ...
Jet fuel is one of an airline's biggest expenditures, typically accounting for around 30% of all costs, totaling billions of dollars per year. Its price can therefore significantly influence each ...
It still retains the original Italian gearbox in which the handbrake is fitted. BHPian Babyhindusthan recently shared this with other enthusiasts: I was just planning to get a new modern car which ...
The Accord got a combined fuel economy of 40 miles per gallon, with city and highway ratings of 34 mpg and 45 mpg, respectively. The Lexus ES Hybrid is a luxury midsize sedan. According to ...
Hyundai’s sales of its fuel cell vehicles have been declining — down 43 per cent in the first half of last year, according to SNE Research. Hydrogen, for all its theoretical appeal ...
Cancer cells can poison attacking immune cells by filling them with defective mitochondria ― dampening the body’s defensive forces and helping the tumour to evade eradication 1. These findings ...
Treatment with the CAR-T cell therapy Yescarta (axicabtagene ciloleucel) continued to demonstrate durable responses after a median follow-up of more than five years in patients with ...